A trial at the University of Kentucky of some 4,000 patients, and just published in the European Heart Journal has found treatment with digoxin in atrial fibrillation (AF), was linked with an increase in deaths.

UK heart experts say although the study found a link between digoxin and deaths, this does not necessarily mean that the drug itself is to blame or that it should no longer be used, the experts insist the drug digoxin is still safe to use.

Natasha Stewart, the BHF Senior Cardiac Nurse said:-
“Heart patients should not be too alarmed by this study as digoxin is not the primary treatment for atrial fibrillation in the UK.
However, there are good reasons why some AF and heart failure patients are still taking digoxin, as it can help them to manage their condition.
Before we jump to any conclusions about the dangers of the drug, we’d need to see further research into what might be causing these increased risks.

Patients who are prescribed digoxin should not stop taking their meds without discussing their concerns with their doctor.”

Source:  The BHF   ;  European Heart Journal